Back to Anacor Homepage Developing Drug Candidates Through Boron Chemistry
Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.
Learn more about the six clinical-stage products
Pipeline

By exploiting the advantages of our boron chemistry platform, we have discovered and advanced into clinical development several novel and proprietary boron-based product candidates that address attractive market opportunities.

[ View pipeline ]

  
Pipeline Graphic		  
 
New Releases

Thursday, May 10, 2012 | Anacor Pharmaceuticals Reports First Quarter 2012 Financial Results
Friday, May 4, 2012 | Anacor Pharmaceuticals to Present Clinical Data on Tavaborole and AN2728 at Upcoming Medical Meetings
Friday, May 4, 2012 | Anacor Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call and Webcast
 
New Releases Graphic		  
 
Scientific Presentations

May 9-12, 2012 - Raleigh, NC

Society for Investigative Dermatology Annual Meeting

March 11-15, 2012 - San Francisco, CA

Society of Toxicology Annual Meeting

October 23-27, 2011 - Washington, DC

American Association of Pharmaceutical Sciences Annual Meeting

October 16-20, 2011 - Atlanta, Georgia

International Society for the Study of Xenobiotics

September 17-20, 2011 - Chicago, IL

51st ICAAC

September 7-10, 2011 - Barcelona, Spain

41st Annual Meeting of the European Society for Dermatological Research
 

SITEMAP | CONTACT | PRIVACY POLICY | TERMS OF USE | HOME

  
 

© 2011 Anacor Pharmaceuticals, Inc., All Rights Reserved.